Lazard Asset Management »

Poseida Therapeutics I shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Poseida Therapeutics I (PSTX) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Poseida Therapeutics I

Tip: Access up to 7 years of quarterly data

All positions including Poseida Therapeutics I held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Poseida Therapeutics I by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $0 7.5k 0.00
2023-09-30 $75k 32k 2.35
2023-06-30 $32k 18k 1.75
2023-03-31 $36k 12k 2.98
2022-12-31 $90k 17k 5.29

More positions owned by Lazard Asset Management

Microsoft Corp Common Stock (MSFT)
Alphabet Inc A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Norfolk Souther Common Stock (NSC)
Visa Common Stock (V)
Accenture Common Stock (ACN)
Intercontinen Common Stock (ICE)
Unitedhealth Gr Common Stock (UNH)
Aon Plc/ireland Common Stock (AON)
Bank Of America Common Stock (BAC)
Thermo Fisher Common Stock (TMO)
Analog Devices Common Stock (ADI)
Mcdonalds Corp Common Stock (MCD)
John & John Common Stock (JNJ)
Amer Express Common Stock (AXP)

View all positions for Lazard Asset Management

Top funds holding Poseida Therapeutics I

Pentwater Capital Management
Vanguard Group
Aisling Capital Management
William Blair $ Company
Millennium Management
Charles Schwab Investment Management
Dimensional Fund Advisors
Goldman Sachs Group
Jacobs Levy Equity Management
Connor, Clark & Lunn Investment Management
Point72 Asset Management
MCF Advisors
Bank of America Corporation
Bank of New York Mellon
Barclays

View all funds holding Poseida Therapeutics I